Johnson & Johnson (JNJ) Current Assets (2009 - 2026)

Johnson & Johnson's (JNJ) quarterly Current Assets came in at $59.2 billion in Q1 2026, down 17.3% year-on-year from $71.6 billion in Q1 2025, and up 6.38% quarter-over-quarter from $55.6 billion in Q4 2025.

Johnson & Johnson (JNJ) Current Assets (2009 - 2026) Analysis & Trends

Johnson & Johnson has disclosed Current Assets across 18 years of filings, most recently posting $59.2 billion for Q1 2026.

  • Current Assets for Q1 2026 came in at $59.2 billion, down 17.3% year-over-year; the trailing twelve-month figure through Mar 2026 was $59.2 billion (down 17.3% YoY), and the FY2025 annual result was $55.6 billion, changed 0.48% from the prior year.
  • Current Assets came in at $59.2 billion for Q1 2026 at Johnson & Johnson, up from $55.6 billion in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $71.6 billion in Q1 2025 to a low of $53.2 billion in Q3 2024.
  • The 5-year median for Current Assets is $57.4 billion (2024), against an average of $58.7 billion.
  • Across the five-year window, Current Assets dropped 17.68% in 2023 and gained 25.52% in 2025, its largest moves.
  • Johnson & Johnson's Current Assets stood at $65.2 billion in 2022, then fell by 18.0% to $53.5 billion in 2023, then increased by 4.48% to $55.9 billion in 2024, then fell by 0.48% to $55.6 billion in 2025, then grew by 6.38% to $59.2 billion in 2026.
  • The last three Current Assets figures came in at $59.2 billion (Q1 2026), $55.6 billion (Q4 2025), and $54.6 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn 23.94 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn 54.84 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn 59.17 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn 33.53 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn 35.02 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn 31.48 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn 18.64 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn 42.82 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn 27.21 Bn
10 Novartis Ag 108.28 Bn 107.60 Bn - -

Historic Data

Download Data
DateValue
Mar 29, 2026 59.17 Bn
Dec 28, 2025 55.62 Bn
Sep 28, 2025 54.61 Bn
Jun 29, 2025 54.50 Bn
Mar 30, 2025 71.55 Bn
Dec 29, 2024 55.89 Bn
Sep 29, 2024 53.25 Bn
Jun 30, 2024 57.82 Bn
Mar 31, 2024 57.00 Bn
Dec 31, 2023 53.50 Bn
Oct 1, 2023 53.70 Bn
Jul 2, 2023 60.57 Bn
Apr 2, 2023 64.39 Bn
Jan 1, 2023 55.29 Bn
Oct 2, 2022 65.24 Bn
Jul 3, 2022 63.85 Bn
Apr 3, 2022 60.42 Bn
Jan 2, 2022 60.98 Bn
Oct 3, 2021 59.89 Bn
Jul 4, 2021 53.77 Bn